Senecavirus
Senecavirus
Senecavirus, also known as Seneca Valley virus (SVV), is a virus that belongs to the family Picornaviridae. It was first identified in pigs in the United States in the 1980s. Senecavirus is a non-enveloped, single-stranded RNA virus that is closely related to other picornaviruses such as foot-and-mouth disease virus.
Discovery[edit | edit source]
Senecavirus was first isolated from pigs with vesicular disease in Seneca Valley, Ohio, hence its name. The virus was initially thought to be a potential pathogen in pigs, causing mild symptoms such as fever, lameness, and vesicular lesions on the snout and feet. However, further research revealed that Senecavirus has oncolytic properties, meaning it can selectively infect and kill cancer cells.
Oncolytic Potential[edit | edit source]
Studies have shown that Senecavirus has oncolytic activity against a variety of human cancers, including small cell lung cancer, melanoma, and neuroendocrine tumors. The virus infects cancer cells by binding to a specific receptor on the cell surface and replicating within the tumor, leading to cell lysis and tumor destruction. This oncolytic effect has generated interest in Senecavirus as a potential cancer therapy.
Clinical Trials[edit | edit source]
Several clinical trials are currently underway to evaluate the safety and efficacy of Senecavirus as a cancer treatment. Early results have shown promising outcomes, with some patients experiencing tumor regression and prolonged survival. Researchers are also investigating the use of Senecavirus in combination with other immunotherapy agents to enhance its anti-cancer effects.
Future Directions[edit | edit source]
As research on Senecavirus continues to advance, scientists are exploring ways to optimize its oncolytic properties and improve its delivery to tumor sites. Additionally, efforts are being made to develop genetically modified versions of the virus that can target specific types of cancer cells more effectively. The potential of Senecavirus as a novel cancer therapy holds great promise for the future of oncolytic virotherapy.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
